Lance Wilkes
Stock Analyst at Bernstein
(3.51)
# 853
Out of 4,667 analysts
24
Total ratings
72.73%
Success rate
14.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lance Wilkes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Outperform | $96 → $88 | $59.10 | +48.90% | 4 | Oct 30, 2024 | |
| HUM Humana | Upgrades: Outperform | $308 | $293.97 | +4.77% | 3 | Oct 8, 2024 | |
| HCA HCA Healthcare | Downgrades: Market Perform | $301 | $333.00 | -9.61% | 4 | Jan 4, 2024 | |
| CI The Cigna Group | Upgrades: Outperform | $372 | $323.39 | +15.03% | 6 | Jan 4, 2024 | |
| UNH UnitedHealth Group | Upgrades: Outperform | $595 → $603 | $600.50 | +0.42% | 4 | Jul 18, 2023 | |
| CVS CVS Health | Maintains: Market Perform | $107 → $93 | $56.83 | +63.65% | 3 | May 2, 2023 |
Centene
Oct 30, 2024
Maintains: Outperform
Price Target: $96 → $88
Current: $59.10
Upside: +48.90%
Humana
Oct 8, 2024
Upgrades: Outperform
Price Target: $308
Current: $293.97
Upside: +4.77%
HCA Healthcare
Jan 4, 2024
Downgrades: Market Perform
Price Target: $301
Current: $333.00
Upside: -9.61%
The Cigna Group
Jan 4, 2024
Upgrades: Outperform
Price Target: $372
Current: $323.39
Upside: +15.03%
UnitedHealth Group
Jul 18, 2023
Upgrades: Outperform
Price Target: $595 → $603
Current: $600.50
Upside: +0.42%
CVS Health
May 2, 2023
Maintains: Market Perform
Price Target: $107 → $93
Current: $56.83
Upside: +63.65%